Literature DB >> 28952359

New-Onset Isolated Asymptomatic Papilledema in Two Patients Treated With Recombinant Growth Hormone.

Lauren Amanda Kanner1,2, Jason Klein1,3, Majida Gaffar4, Howard Pomeranz4, Graeme Frank1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28952359      PMCID： PMC5638670          DOI： 10.1177/0009922817698808

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  13 in total

1.  Papilledema Without Increased Intracranial Pressure.

Authors:  A J Bedell
Journal:  Trans Am Ophthalmol Soc       Date:  1941

2.  Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment.

Authors:  Dorothea Besch; Christine Makowski; Marc-Matthias Steinborn; Walter Bonfig; Bettina Sadowski
Journal:  Neuropediatrics       Date:  2012-12-28       Impact factor: 1.947

3.  Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy.

Authors:  I Francois; I Casteels; J Silberstein; P Casaer; F de Zegher
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

4.  Papilledema in 15 renally compromised patients treated with growth hormone.

Authors:  E A Koller; B V Stadel; S N Malozowski
Journal:  Pediatr Nephrol       Date:  1997-08       Impact factor: 3.714

5.  Lessons from the national cooperative growth study.

Authors:  David Wyatt
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

6.  Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand.

Authors:  P A Crock; J D McKenzie; A M Nicoll; N J Howard; W Cutfield; L K Shield; G Byrne
Journal:  Acta Paediatr       Date:  1998-04       Impact factor: 2.299

7.  Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment.

Authors:  A Vischi; S Guerriero; G Giancipoli; V Lorusso; G Sborgia
Journal:  Eur J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.597

8.  Pseudopapilledema and congenital disc anomalies in growth hormone deficiency.

Authors:  P F Collett-Solberg; G T Liu; M Satin-Smith; L L Katz; T Moshang
Journal:  J Pediatr Endocrinol Metab       Date:  1998 Mar-Apr       Impact factor: 1.634

9.  Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.

Authors:  S Malozowski; L A Tanner; D K Wysowski; G A Fleming; B V Stadel
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

10.  Prolonged Intracranial Hypertension after Recombinant Growth Hormone Therapy due to Impaired CSF Absorption.

Authors:  Kaoru Obinata; Ayako Kamata; Keiji Kinoshita; Tomoyuki Nakazawa; Hidenori Haruna; Atsuto Hosaka; Toshiaki Shimizu
Journal:  Clin Pediatr Endocrinol       Date:  2010-05-22
View more
  1 in total

1.  Evaluation of the underlying causes of papilledema in children.

Authors:  Robert A Hyde; Mehmet C Mocan; Urmi Sheth; Lawrence M Kaufman
Journal:  Can J Ophthalmol       Date:  2019-04-04       Impact factor: 1.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.